Promising Early Results for Stress Urinary Incontinence Device

Image credit: UroMems

Early results from a smart artificial urinary sphincter implanted in a woman in France last year show a promising future pathway for treating stress urinary incontinence (SUI) in both women and men.

Global medtech, UroMems has confirmed the six-month primary endpoint has been met for the first-ever female patient implanted with its UroActive System – an electronic artificial urinary sphincter which works to offset sphincter insufficiency in patients with SUI.

The technology combines smart, digital and robotic systems, operating from a bespoke treatment algorithm based on individual patient data.

The first woman implanted with the device is reported to have experienced restored social continence and remained revision-free, with follow-up secondary measures including leak rate values also noted as “extremely positive”.

UroActive is claimed to be the first smart active implantable device for treating SUI, powered by the company’s MyoElectroMechanical System which is placed around the urethra in men and the bladder neck in women.

“We are elated to reach this critical achievement contributing to the demonstration of the feasibility of the UroActive System to successfully treat women suffering from debilitating SUI,” said UroMems CEO and Co-Founder, Hamid Lamraoui in a statement.

“The compelling results of this first-in-female implant show the high potential of our technology, bringing us one step closer to delivering on the massive unmet need for women and physicians desperately seeking a better SUI treatment option.”

Refer to the full statement via UroMems for further details.